Publications by authors named "Volker Kinast"

Claim this Profile
I
Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture models.
Sarah Schlienkamp, Olinda Pinto Veiga, André Gömer, Luca Nörthemann, Leyla Sirkinti, Volker Kinast

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How hepatitis E virus invades hepatocytes: the mystery of viral entry.
Yannick Brüggemann, Nicola Frericks, Emely Richter, Volker Kinast, Eike Steinmann

Trends Microbiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cellular cathepsins inhibits hepatitis E virus entry.
Mara Klöhn, Thomas Burkard, Juliana Janzen, Jil A Haase, André Gömer, Volker Kinast

Hepatology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tyrosine kinase Yes1 is a druggable host factor of HEV.
Jil Alexandra Haase, Abarna Baheerathan, Xin Zhang, Rebecca Menhua Fu, Maximilian Klaus Nocke, Volker Kinast

Hepatol Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential risk of porcine-derived pancreatic enzyme medication for the cross-species transmission of hepatitis E virus.
Nicola Frericks, Volker Kinast, Eike Steinmann

Gut· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.
Isabelle Reichert, Ji-Young Lee, Laura Weber, Marceline M Fuh, Lina Schlaeger, Volker Kinast

PLoS Pathog· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast, Marcela Moncada-Velez, Alison W Ashbrook

PLoS Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relation of host genetics to symptomatic hepatitis E.
Volker Kinast, Daniel Todt

Hepatology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase-inhibition modulates hepatitis E virus infection.
Volker Kinast, Ioana Andreica, Gerrit Ahrenstorf, André Gömer, Carina Elsner

Antiviral Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine Hepaciviruses.
Yudi Zhang, Volker Kinast, Julie Sheldon, Nicola Frericks, Daniel Todt

Microbiol Spectr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGF receptor modulates HEV entry in human hepatocytes.
Jil A Schrader, Thomas L Burkard, Yannick Brüggemann, André Gömer, Toni L Meister, Volker Kinast

Hepatology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
Ute Gravemann, Michael Engelmann, Volker Kinast, Thomas Burkard, Patrick Behrendt

Transfusion· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus species barriers: seeking viral and host determinants.
Volker Kinast, Mara Klöhn, Maximilian K Nocke, Daniel Todt, Eike Steinmann

Curr Opin Virol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Dimas F Praditya, Mara Klöhn, Yannick Brüggemann, Lauren E Brown, John A Porco, Volker Kinast

Antiviral Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus is highly resistant to alcohol-based disinfectants.
Patrick Behrendt, Martina Friesland, Jan-Erik Wißmann, Volker Kinast, Yannick Stahl

J Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes.
Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Volker Kinast

iScience· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis.
Birthe Reinecke, Mara Klöhn, Yannick Brüggemann, Volker Kinast, Daniel Todt

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
Volker Kinast, Agnieszka Plociennikowska, Anggakusuma, Thilo Bracht, Daniel Todt

J Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Daniel Todt, Martina Friesland, Nora Moeller, Dimas Praditya, Volker Kinast

Proc Natl Acad Sci U S A· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment.
Bernhard Schlevogt, Volker Kinast, Julia Reusch, Andrea Kerkhoff, Dimas Praditya

Pathogens· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver.
Volker Kinast, Stefan L Leber, Richard J P Brown, Gabrielle Vieyres, Patrick Behrendt

Cells· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E Virus Drug Development.
Volker Kinast, Thomas L Burkard, Daniel Todt, Eike Steinmann

Viruses· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines.
Jennifer Becker, Volker Kinast, Marius Döring, Christoph Lipps, Veronica Duran

Virulence· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylene Blue Treatment of Grafts During Cold Ischemia Time Reduces the Risk of Hepatitis C Virus Transmission.
Fabian A Helfritz, Denisa Bojkova, Verena Wanders, Nina Kuklinski, Sandra Westhaus, Volker Kinast

J Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Daniel Todt, Nora Moeller, Dimas Praditya, Volker Kinast, Martina Friesland

Antiviral Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis